What does the current evidence tell us about the cardiovascular impact of novel tobacco and nicotine products?
In this presentation from Global Forum on Nicotine 2026, Dr. Thomas Nahde discusses a narrative review examining cardiovascular health and the potential impact of switching from combustible cigarettes to non-combustible nicotine products.
The review brings together 221 publications, covering experimental research, clinical studies and population-level evidence. It examines cardiovascular toxicant exposure, biomarkers of potential harm, atherosclerosis-related mechanisms, and evidence surrounding e-cigarettes, heated tobacco products and nicotine pouches.
Sep 29
26 min
France has recently prohibited nicotine pouches. Jean-François Etter discusses what prohibition could mean for consumers, quality control, illicit markets and criminal groups and why the demand for nicotine pouches may not simply disappear.
Sep 24
3 min
What Does Real-World Use Tell Us About Blu? | #GFN26ScienceLab by GFN.TV
Sep 21
16 min
A clear and worsening division within public health has turned the debate over nicotine into a moral panic, with potentially dire consequences. Shot on location at GFN 2026 in Warsaw, Poland, longtime nicotine researcher and former University of Geneva professor of public health Jean-François Etter examines the irrational push to prohibit safer nicotine products. He explores public health groupthink, how arbitrary nicotine limits leave people underdosed, and why innovation may ultimately render opponents of tobacco harm reduction obsolete.
Featuring:
JEAN-FRANÇOIS ETTER
Nicotine & Tobacco Harm Reduction Researcher
Former Prof. of Public Health, University of Geneva
@etterjfZ
profetter.substack.com
Sep 18
28 min
A harm reduction approach should not stop at those who are still smoking. What about the millions who have already moved to safer nicotine products - and still depend on access to them? If public health is about reducing harm, shouldn’t their voices count too?
Sep 16
2 min
Which oral nicotine products carry the greatest risk to oral health?
In this GFN Science Lab presentation, Helen Cowie examines how the shift from smoking to smokeless and oral nicotine products changes the way tobacco harm reduction should be assessed.
The discussion explores the current evidence on oral health risks across different product categories, including combustible cigarettes, traditional oral tobacco, snus and nicotine pouches. While cigarettes and several traditional oral tobacco products have well-established oral health harms, the presentation highlights evidence suggesting a substantially lower risk profile for oral nicotine pouches compared with smoking.
Sep 14
17 min
A safer alternative exists - but why is it so often treated differently? When harm reduction depends on meeting people where they are, where do smokers fit in? The answer may challenge some long-held assumptions about nicotine, choice, and public health.
Sep 11
2 min
How does the scientific evidence on heated tobacco products (HTPs) compare with what we know about cigarette smoking? In this presentation from the GFN Science Lab, Dr. Leonie Price takes a look at multiple layers of evidence surrounding heated tobacco products — from aerosol chemistry and toxicant emissions to biomarkers of exposure, environmental exposure, and the behavior of smokers who switch to HTPs.
Sep 7
23 min
In the global war on nicotine, many are pushed to the margins. It’s not just smokers who no longer count. Adults who’ve already made the switch to safer nicotine no longer count. Independent vape retailers, consumer advocates and accomplished scientists and researchers are shunned and sometimes silenced. Even the proven real-world consequences of prohibition no longer count. Shot on location at the Global Forum on Nicotine in Warsaw, Poland, GFN organizer Paddy Costall reflects on 13 years of organized resistance to the moral crusade against safer nicotine.
Featuring:
PADDY COSTALL
Event Organizer, Global Forum on Nicotine
gfn.events
Sep 4
33 min
Banning products doesn’t necessarily eliminate demand. Prohibition can push consumers toward black markets, reduce regulatory control, and create unintended consequences for public health.
Timur Abdullaev explored prohibition, tobacco harm reduction, nicotine policy, and the challenges of trying to reduce smoking through increasingly restrictive policies. He also examined why nicotine, tobacco, and smoking should not be treated as synonymous — and what happens when they are.
Sep 2
4 min
Load more